CHD and respiratory syncytial virus: global expert exchange recommendations

Abstract

Evidence-based immunoprophylaxis recommendations were formulated for subgroups of children with CHD, but more data are needed to guide use in tropical/subtropical countries and in children with certain co-morbidities.